Benjamin C Yaden is an expert in Pharmacy at Indiana University – Purdue University Indianapolis (United States). Benjamin C Yaden has authored 15 publications, the most recent in 2024. SLR score: 43 (community average: 125). How the SLR is computed.

LeadR Profile

43 ScienceLeadR Reputation 43
Network Map

Pharmacy

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2014 - 2024

Source: PubMed

Indiana University – Purdue University Indianapolis

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 15

Citations

Citations: 537 1st author: 2 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity.
PMID 39418098 — aging, longevity, biomarkers, biotechnology, research, artificial intelligence, geroscience
Aging (Albany NY)20248
Gastrointestinal pharmacology activins in liver health and disease.
PMID 37364623 — liver diseases, biochemistry, non-alcoholic fatty liver disease, chemistry, pharmaceutical, follistatin, liver, inhibins, pharmacology, therapeutics, activins
Biochem Pharmacol20234
GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting.
PMID 37509548 — injections, ligands, liver, muscle, skeletal, muscular atrophy, muscles
Biomedicines20232
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis.
PMID 36996941 — liver diseases, cells, genes, activating transcription factor 4, hepatocytes, carcinogens, transcription factors, non-alcoholic fatty liver disease, antiporters, stress, physiological, neoplasms, cystine, ferroptosis, liver, diet, cell death, hepatitis, glutathione
J Hepatol2023182
Activin B promotes the initiation and progression of liver fibrosis.
PMID 35866567 — liver diseases, cells, activins, fibrosis, nitric oxide synthase, jnk mitogen-activated protein kinases, poly adenosine diphosphate ribose, poly(adp-ribose) polymerases
Hepatol Commun20227

LeadR Networks

Main global connection map